NCT05088850

The Early Prediction of Sepsis in ICU

Status unknown Last updated 22 October 2021

What this trial tests

trial testing no intervention in Prediction of Sepsis in Critical Patients in 400 participants. Status unknown.

Timeline

30 May 2020

Primary endpoint
31 December 2022

31 December 2023

Quick facts

Lead sponsor	Ruijin Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	400
Start date	30 May 2020
Primary completion	31 December 2022
Estimated completion	31 December 2023
Sites	1 location across China

Drugs / interventions tested

• no intervention

Conditions studied

• Prediction of Sepsis in Critical Patients — all drugs for Prediction of Sepsis in Critical Patients →

Sponsor

Ruijin Hospital

Who can join

14 and older, any sex, with Prediction of Sepsis in Critical Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sepsis is a vital issue in critical care medicine, and early detection and intervention are key to survival. We aimed to establish an early warning system for sepsis based on a data integration platform that can be implemented in the ICU.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

1. Transferability and interpretability of the sepsis prediction models in the intensive care unit.
   Chen Q, Li R, Lin C, Lai C, et al · · 2022 · cited 9× · PMID 36581881 · DOI 10.1186/s12911-022-02090-3
2. Transferability and interpretability of the sepsis prediction models in the intensive care unit
   Chen Q, Li R, Lin C, Lai C, et al · · 2021 · DOI 10.1101/2021.05.13.21256281